First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

标题
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
作者
关键词
Glaucoma, Trabeculectomy, Surgical and invasive medical procedures, Eyes, Ophthalmic procedures, Visual acuity, Cornea, Optic disc
出版物
PLoS One
Volume 12, Issue 11, Pages e0188899
出版商
Public Library of Science (PLoS)
发表日期
2017-12-01
DOI
10.1371/journal.pone.0188899

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now